March 26, 2025 - 14:39

Gorilla Technology is preparing to unveil its full-year financial performance for 2024, with key results expected to be announced on March 31. This much-anticipated disclosure will provide stakeholders with a detailed look at the company’s financial health and operational achievements over the past year.
In addition to the financial metrics, the management team will share insights into the strategic direction of the company, outlining growth plans and initiatives aimed at enhancing market position. Investors and analysts alike are keen to understand how Gorilla Technology navigated the challenges of the previous year and what measures have been implemented to drive future success.
The upcoming announcement is expected to highlight significant developments, including revenue growth, cost management strategies, and innovations that may influence the company's trajectory moving forward. As the date approaches, all eyes will be on Gorilla Technology to see how its performance aligns with market expectations and investor confidence.
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...